← Evidence map

ArticleClinical and molecular hepatology2024

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study".

Yewan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study". | OpenQuestion